Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases

被引：13

作者：

Enkvist, Erki ^{[1
]}

Kriisa, Marie ^{[1
]}

Roben, Mart ^{[1
]}

Kadak, Grete ^{[1
]}

Raidaru, Gerda ^{[1
]}

Uri, Asko ^{[1
]}

机构：

[1] Univ Tartu, Inst Chem, EE-51014 Tartu, Estonia

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 21期

关键词：

Protein kinases; AGC kinases; PKA; PKB/Akt; ROCK; Bisubstrate inhibitors; Oligoarginine; PEPTIDE INHIBITORS; DISCOVERY; DESIGN; AKT;

D O I：

10.1016/j.bmcl.2009.09.026

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Previously reported structural fragments that associate with the ATP-binding pocket of basophilic protein kinases were conjugated with D-arginine-containing peptides. Inhibitory potency of the resulting bisubstrate-analog inhibitors towards PKA and ROCK-II extended to subnanomolar range. The conjugates incorporating 2-pyrimidyl-5-amidothiophene fragment had the highest activity and at 100 nM concentration exhibited over 80% inhibition of most of the tested basophilic kinases of the AGC group. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：6098 / 6101

页数：4

共 17 条

[1] ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II
Ahn, Dae-Ro
Han, Ki-Cheol
Kwon, Hyuk Sung
Yang, Eun Gyeong
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) : 147 - 151
[2] Peptide inhibitors of protein kinases - discovery, characterisation and use
Bogoyevitch, MA
Barr, RK
Ketterman, AJ
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2): : 79 - 99
[3] Protein kinases - the major drug targets of the twenty-first century?
Cohen, P
[J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) : 309 - 315
[4] Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases
Enkvist, Erki
Lavogina, Darja
Raidaru, Gerda
Vaasa, Angela
Viil, Indrek
Lust, Marje
Viht, Kaido
Uri, Asko
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) : 7150 - 7159
[5] The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases
Fischer, PM
[J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (12) : 1563 - 1583
[6] Protein kinase inhibitors: contributions from structure to clinical compounds
Johnson, Louise N.
[J]. QUARTERLY REVIEWS OF BIOPHYSICS, 2009, 42 (01) : 1 - 40
[7] Structural Analysis of ARC-Type Inhibitor (ARC-1034) Binding to Protein Kinase A Catalytic Subunit and Rational Design of Bisubstrate Analogue Inhibitors of Basophilic Protein Kinases
Lavogina, Darja
Lust, Marje
Viil, Indrek
Koenig, Norbert
Raidaru, Gerda
Rogozina, Jevgenia
Enkvist, Erki
Uri, Asko
Bossemeyer, Dirk
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) : 308 - 321
[8] Stepwise combinatorial evolution of Akt bisubstrate inhibitors
Lee, Jung Hwan
Kumar, Sanjai
Lawrence, David S.
[J]. CHEMBIOCHEM, 2008, 9 (04) : 507 - 509
[9] Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies
Lin, Xiaodong
Murray, Jeremy M.
Rico, Alice C.
Wang, Michael X.
Chu, Daniel T.
Zhou, Yasheen
Del Rosario, Merci
Kaufman, Susan
Ma, Sylvia
Fang, Eric
Crawford, Kenneth
Jefferson, A. B.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4163 - 4168
[10] Designing bisubstrate analog inhibitors for protein kinases
Parang, K
Cole, PA
[J]. PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) : 145 - 157

← 1 2 →